<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-410FG8LT</identifier><date>2020</date><creator>Barbič-Žagar, Breda</creator><creator>Krevel, Barbara</creator><creator>Uranič, Nataša</creator><relation>documents/doc/4/URN_NBN_SI_doc-410FG8LT_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-410FG8LT_001.txt</relation><format format_type="issue">1</format><format format_type="volume">59</format><format format_type="type">article</format><format format_type="extent">str. 107-118</format><identifier identifier_type="ISSN">0025-8121</identifier><identifier identifier_type="COBISSID">20493059</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-410FG8LT</identifier><language>slv</language><publisher publisher_location="Ljubljana">Medicinski razgledi</publisher><source>Medicinski razgledi</source><rights>InC</rights><subject language_type_id="slv">bolečina v nogah</subject><subject language_type_id="slv">kronična venska bolezen</subject><subject language_type_id="slv">mikroniziran diosmin</subject><subject language_type_id="slv">učinkovitost</subject><subject language_type_id="slv">varnost</subject><title>The efficacy and safety of a daily 1.000 mg dose of Flebaven (diosmin) in patients with chronic venous disease</title><title>Učinkovitost in varnost enega odmerka Flebavena (diosmin) po 1.000 mg dnevno pri bolnikih s kronično vensko boleznijo</title></Record>